Health Care & Life Sciences » Pharmaceuticals | Axim Biotechnologies Inc.

Axim Biotechnologies Inc.

Axim Biotechnologies Inc.
Stock Exchange Other OTC
EPS
$0.11
Market Cap
$50.49 M
Shares Outstanding
61.57 M
Public Float
12.42 M

Profile

Address
45 Rockefeller Plaza
New York New York 10111
United States
Employees -
Website http://www.aximbiotech.com
Updated 07/08/2019
AXIM Biotechnologies, Inc. engages in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand.

Financials

View All
Created with Highcharts 5.0.14Axim Biotechnologies Inc.Net Income. Fiscal year is January-December. All values USD Thousands.898953853810 09210 0925 8095 8094 1684 1686 7546 75420132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Axim Biotechnologies Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.212100494947474747195195201320142015201620172018050100150200250

George E. Anastassov
Chairman, President & Chief Executive Officer
Lekhram Changoer
Director & Chief Technology Officer